World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
17318
World Ranking
2330
National Ranking
60

Aeron C. Hurt publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Aeron C. Hurt sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 217 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Aeron C. Hurt D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Aeron C. Hurt sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Aeron C. Hurt is affiliated with Roche (Switzerland) in Switzerland and specializes in research within the fields of medicine and immunology and microbiology. Their main areas of study include epidemiology, immunology, infectious diseases, agronomy and crop science, and animal science and zoology.

The primary topics covered in their research consist of influenza virus research studies, viral infections and vectors, respiratory viral infections research, immune response and inflammation, animal disease management and epidemiology, interferon and immune responses, and animal virus infections studies.

Frequent co-authors collaborating with Aeron C. Hurt include Marios Koutsakos, Michelle Wille, Edward C. Holmes, Adam K. Wheatley, and Stephen J. Kent.

Regular publication venues for their work are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Influenza and Other Respiratory Viruses
  • Virology
  • Nature Communications
  • Journal of Virology

Selected recent publications by Aeron C. Hurt include:

  • Sustained RNA virome diversity in Antarctic penguins and their ticks, 2020, The ISME Journal
  • Understanding the Impact of Resistance to Influenza Antivirals, 2021, Clinical Microbiology Reviews
  • RNA virome abundance and diversity is associated with host age in a bird species, 2021, Virology
  • Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients, 2021, Nature Communications
  • The impact of climate and antigenic evolution on seasonal influenza virus epidemics in Australia, 2020, Nature Communications

Best Publications

  • Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

    Hayden Fg;Sugaya N;Hirotsu N;Lee N

  • The Global Circulation of Seasonal Influenza A (H3N2) Viruses

    Colin A. Russell;Terry C. Jones;Terry C. Jones;Terry C. Jones;Ian G. Barr;Nancy J. Cox

  • Global circulation patterns of seasonal influenza viruses vary with antigenic drift.

    Trevor Bedford;Steven Riley;Ian G. Barr;Shobha Broor

  • Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

    Björn F. Koel;David F. Burke;Theo M. Bestebroer;Stefan van der Vliet

  • Antibody landscapes after influenza virus infection or vaccination

    J. M. Fonville;J. M. Fonville;J. M. Fonville;S. H. Wilks;S. H. Wilks;S. L. James;S. L. James;A. Fox

  • Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.

    Aeron C. Hurt;Joanne Ernest;Yi-Mo Deng;Pina Iannello

  • Performance of six influenza rapid tests in detecting human influenza in clinical specimens

    Aeron C. Hurt;Aeron C. Hurt;Robert Alexander;Jan Hibbert;Nicola Deed

  • Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses

    Colin A. Russell;Terry C. Jones;Terry C. Jones;Terry C. Jones;Ian G. Barr;Nancy J. Cox

  • Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation

    Aeron C. Hurt;Jessica K. Holien;Michael Parker;Michael Parker;Anne Kelso

  • Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.

    Aeron Christopher Giles Hurt;Paul Selleck;Naomi Komadina;Robert P Shaw

  • Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives.

    Aeron C Hurt;Tawee Chotpitayasunondh;Nancy J Cox;Rod Daniels

  • Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia.

    George G. Arzey;Peter D. Kirkland;K. Edla Arzey;Melinda Frost

  • Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015

    Adam Meijer;Helena Rebelo-de-Andrade;Helena Rebelo-de-Andrade;Vanessa Correia;Vanessa Correia;Terry Besselaar

  • Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

    Marios Koutsakos;Patricia T. Illing;Thi H. O. Nguyen;Nicole A. Mifsud

  • The contrasting phylodynamics of human influenza B viruses

    Dhanasekaran Vijaykrishna;Edward C. Holmes;Udayan Joseph;Mathieu Fourment

  • Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity.

    Marios Koutsakos;Adam K. Wheatley;Liyen Loh;E. Bridie Clemens

  • The epidemiology and spread of drug resistant human influenza viruses

    Aeron C Hurt

  • Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia

    A. C. Hurt;K. Hardie;N. J. Wilson;Yi-Mo Deng

  • Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.

    Takeki Uehara;Frederick G Hayden;Keiko Kawaguchi;Shinya Omoto

  • Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013

    Unknown

  • Influenza antivirals currently in late-phase clinical trial.

    Paulina Koszalka;Danielle Tilmanis;Aeron C. Hurt

Frequent Co-Authors

Ian G. Barr
Ian G. Barr University of Melbourne
Sebastian Maurer-Stroh
Sebastian Maurer-Stroh Agency for Science, Technology and Research
Anne Kelso
Anne Kelso University of Melbourne
Dhanasekaran Vijaykrishna
Dhanasekaran Vijaykrishna University of Hong Kong
Stephen J. Kent
Stephen J. Kent University of Melbourne
Dominic E. Dwyer
Dominic E. Dwyer University of Sydney
Edward C. Holmes
Edward C. Holmes University of Sydney
James M. McCaw
James M. McCaw University of Melbourne
Jesse D. Bloom
Jesse D. Bloom Fred Hutchinson Cancer Research Center
Marcel Klaassen
Marcel Klaassen Deakin University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open up diverse career opportunities. Many students transition into advanced nursing roles which complement their understanding of immune system disorders. Programs like the best online pmhnp programs offer excellent clinical placement rates, preparing graduates for specialized psychiatric care which often involves immunological factors.

Cost is always a consideration, and the cheapest psychiatric nurse practitioner programs provide budget-friendly options without sacrificing quality. These affordable pathways help aspiring nurse practitioners gain credentials quickly and efficiently.

Career growth potential is significant, with some fields among the highest paid dnp specialties. Advanced practice nurses with a focus on immunology-related conditions often achieve higher salaries and better job security.

Additionally, nurses can enhance their qualifications by pursuing certifications like the acute care certification for fnp. This enables a smooth transition from family nurse practitioner roles to acute care settings, where immunology expertise is highly relevant.

Best Scientists Citing Aeron C. Hurt

Trending Scientists

Recently Published Articles